{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T16:40:06Z","timestamp":1750005606693,"version":"3.41.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:p>Some physicians and parents request to measure antimeasles serum IgG antibodies after measles-mumps-rubella (MMR) vaccination. Often, vaccine skeptical parents want to know if their child is \u201cimmune\u201d after the first dose to avoid the second dose. In the usual healthy child, this should be discouraged for the following reasons. Commercially available antibody assays do not measure functional (neutralizing) antibodies. They cannot reliably measure immunity against measles and were designed to measure naturally acquired antibodies rather than those induced by vaccination. Furthermore, MMR also includes mumps and rubella vaccine viruses, which also require 2 doses for optimal protection; there is no reliable serologic correlate of protection for mumps. Therefore, the 2-dose MMR immunization concept is by far more effective, efficient and reliable than a single dose strategy based on a post-dose 1 positive anti-measles-IgG test. Consequently, physicians should resist the desire to measure antimeasles IgG antibodies unless there is a clear indication (e.g., immunodeficiency) or official recommendation as part of the national immunization program.<\/jats:p>","DOI":"10.1097\/inf.0000000000003519","type":"journal-article","created":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T17:00:13Z","timestamp":1650560413000},"page":"490-491","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Titerphilia - The Irresistible Urge to Measure Postimmunization Antibody Values"],"prefix":"10.1097","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8901-6778","authenticated-orcid":false,"given":"Ulrich","family":"Heininger","sequence":"first","affiliation":[{"name":"University of Basel Children\u2019s Hospital, Paediatric Infectious Diseases and Vaccinology Unit, Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4950-7016","authenticated-orcid":false,"given":"Stanley","family":"Plotkin","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,5,6]]},"reference":[{"key":"R1-20250615","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/INF.0000000000002509","article-title":"What matters to parents regarding immunization of their children: systematic analysis of expert advice to parents in an internet forum.","volume":"39","author":"Imahorn","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"R2-20250615","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/14760584.2019.1559063","article-title":"Current perspectives in assessing humoral immunity after measles vaccination.","volume":"18","author":"Haralambieva","year":"2019","journal-title":"Expert Rev Vaccines"},{"key":"R3-20250615","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s10875-010-9420-7","article-title":"Humoral and cellular immune responses to measles and tetanus: the importance of elapsed time since last exposure and the nature of the antigen.","volume":"30","author":"Viana","year":"2010","journal-title":"J Clin Immunol"},{"key":"R4-20250615","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jcv.2006.12.017","article-title":"Vaccinated students with negative enzyme immunoassay results show positive measles virus-specific antibody levels by immunofluorescence and plaque neutralisation tests.","volume":"38","author":"Tischer","year":"2007","journal-title":"J Clin Virol"},{"key":"R5-20250615","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination.","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"R7-20250615","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00006454-199601000-00007","article-title":"Measles outbreaks in the United States, 1987 through 1990.","volume":"15","author":"Hutchins","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"R8-20250615","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJM199411243312101","article-title":"The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.","volume":"331","author":"Peltola","year":"1994","journal-title":"N Engl J Med"},{"key":"R9-20250615","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.vaccine.2011.12.048","article-title":"The concept of vaccination failure.","volume":"30","author":"Heininger","year":"2012","journal-title":"Vaccine"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003519","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T16:00:14Z","timestamp":1750003214000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,6]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003519","relation":{},"ISSN":["0891-3668"],"issn-type":[{"type":"print","value":"0891-3668"}],"subject":[],"published":{"date-parts":[[2022,5,6]]}}}